NASDAQ:CDLX - Cardlytics Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $13.75 -0.90 (-6.14 %) (As of 11/19/2018 02:43 PM ET)Previous Close$14.65Today's Range$13.73 - $14.3452-Week Range$11.10 - $28.29Volume8,450 shsAverage Volume149,560 shsMarket Capitalization$296.87 millionP/E Ratio-1.75Dividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsInsider TradesInstitutional OwnershipHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cardlytics, Inc. operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. It also provides solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded in 2008 and is headquartered in Atlanta, Georgia. Receive CDLX News and Ratings via Email Sign-up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Computer programming, data processing, & other computer related Sub-IndustryN/A SectorBusiness Services Current SymbolNASDAQ:CDLX Previous Symbol CUSIPN/A Webwww.cardlytics.com Phone888-798-5802 Debt Debt-to-Equity Ratio0.91 Current Ratio3.04 Quick Ratio3.04 Price-To-Earnings Trailing P/E Ratio-1.75 Forward P/E Ratio-6.61 P/E GrowthN/A Sales & Book Value Annual Sales$130.37 million Price / Sales2.14 Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)($8.02) Net Income$-19,640,000.00 Net Margins-32.03% Return on EquityN/A Return on Assets-25.60% Miscellaneous Employees342 Outstanding Shares20,260,000Market Cap$296.87 million OptionableNot Optionable Cardlytics (NASDAQ:CDLX) Frequently Asked Questions What is Cardlytics' stock symbol? Cardlytics trades on the NASDAQ under the ticker symbol "CDLX." How were Cardlytics' earnings last quarter? Cardlytics Inc (NASDAQ:CDLX) released its earnings results on Tuesday, November, 13th. The company reported ($0.15) EPS for the quarter, topping analysts' consensus estimates of ($0.63) by $0.48. The firm had revenue of $34.58 million for the quarter, compared to the consensus estimate of $37.62 million. The firm's revenue was up 10.1% on a year-over-year basis. View Cardlytics' Earnings History. When is Cardlytics' next earnings date? Cardlytics is scheduled to release their next quarterly earnings announcement on Monday, March 18th 2019. View Earnings Estimates for Cardlytics. What guidance has Cardlytics issued on next quarter's earnings? Cardlytics issued an update on its FY 2018 earnings guidance on Tuesday, November, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $146-148 million, compared to the consensus revenue estimate of $154.43 million.Cardlytics also updated its Q4 2018 guidance to EPS. What price target have analysts set for CDLX? 8 Wall Street analysts have issued 1 year price objectives for Cardlytics' shares. Their forecasts range from $20.00 to $28.00. On average, they expect Cardlytics' stock price to reach $24.2857 in the next twelve months. This suggests a possible upside of 76.6% from the stock's current price. View Analyst Price Targets for Cardlytics. What is the consensus analysts' recommendation for Cardlytics? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cardlytics. What are Wall Street analysts saying about Cardlytics stock? Here are some recent quotes from research analysts about Cardlytics stock: 1. According to Zacks Investment Research, "Cardlytics, Inc. is engaged in developing a purchase intelligence platform. The purchase data includes debit, credit and bill pay data from online and in-store transactions. It helps the marketers identify, reach and influence likely buyers at scale, and measure the impact of marketing spends. The Company also operates an advertising channel, Cardlytics Direct. Cardlytics Direct delivers tailored marketing for marketers and financial institutions. Cardlytics, Inc. is based in ATLANTA, United States. " (10/16/2018) 2. SunTrust Banks, Inc. analysts commented, "We hosted CDLX mgt for an NDR this week, during which mgt provided more color around the state of the business following 2Q earnings on 8/14, and progress on the all-important JPM Fargo relationships. As a digital ad channel designed to be bot and fraud proof with attractive ROI, CDLX is gaining enough scale with users and becoming a more relevant platform for advertisers, in our view. The focus now is on-boarding these two new partners while aggressively expanding the sales force to sell the growing ad inventory. We remain positive on CDLX and see ample opportunity for growth. Becoming The Industry Consolidator." (9/11/2018) Has Cardlytics been receiving favorable news coverage? News coverage about CDLX stock has been trending somewhat positive this week, according to InfoTrie Sentiment. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cardlytics earned a coverage optimism score of 0.9 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 9.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the next several days. Who are some of Cardlytics' key competitors? Some companies that are related to Cardlytics include TrueCar (TRUE), Internet Initiative Japan (IIJI), Jianpu Technology (JT), HealthStream (HSTM), Aurora Mobile (JG), Model N (MODN), The Rubicon Project (RUBI), Internap (INAP), Synacor (SYNC), Sify Technologies (SIFY), Chinanet Online (CNET), GigaMedia (GIGM), Autoweb (AUTO), MassRoots (MSRT) and Professional Diversity Network (IPDN). Who are Cardlytics' key executives? Cardlytics' management team includes the folowing people: Mr. Scott D. Grimes, Co-Founder, CEO & Director (Age 55)Ms. Lynne Marie Laube, Co-Founder, COO & Director (Age 48)Mr. David Evans, CFO & Head of Corp. Devel.Mr. Sathish Gaddipati, Chief Technology Officer (Age 51)Mr. Kirk L. Somers, Chief Legal & Privacy Officer (Age 53) When did Cardlytics IPO? (CDLX) raised $76 million in an initial public offering on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers. Who are Cardlytics' major shareholders? Cardlytics' stock is owned by many different of retail and institutional investors. Top institutional investors include FMR LLC (15.77%), Jennison Associates LLC (3.94%), Frontier Capital Management Co. LLC (3.51%), BlackRock Inc. (2.08%), Emerald Mutual Fund Advisers Trust (1.36%) and Allianz Asset Management GmbH (0.84%). Company insiders that own Cardlytics stock include David Thomas Evans, Kirk Somers, Lynne Marie Laube, Polaris Venture Management Co and Scott D Grimes. View Institutional Ownership Trends for Cardlytics. Which major investors are selling Cardlytics stock? CDLX stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., JPMorgan Chase & Co. and Jennison Associates LLC. Company insiders that have sold Cardlytics company stock in the last year include David Thomas Evans, Kirk Somers, Lynne Marie Laube, Polaris Venture Management Co and Scott D Grimes. View Insider Buying and Selling for Cardlytics. Which major investors are buying Cardlytics stock? CDLX stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Frontier Capital Management Co. LLC, Allianz Asset Management GmbH, Emerald Mutual Fund Advisers Trust, North Fourth Asset Management LP, BlackRock Inc., Monashee Investment Management LLC and SG Americas Securities LLC. Company insiders that have bought Cardlytics stock in the last two years include David Thomas Evans and Scott D Grimes. View Insider Buying and Selling for Cardlytics. How do I buy shares of Cardlytics? Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Cardlytics' stock price today? One share of CDLX stock can currently be purchased for approximately $13.75. How big of a company is Cardlytics? Cardlytics has a market capitalization of $296.87 million and generates $130.37 million in revenue each year. The company earns $-19,640,000.00 in net income (profit) each year or ($8.02) on an earnings per share basis. Cardlytics employs 342 workers across the globe. What is Cardlytics' official website? The official website for Cardlytics is http://www.cardlytics.com. How can I contact Cardlytics? Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The company can be reached via phone at 888-798-5802 or via email at [email protected] MarketBeat Community Rating for Cardlytics (NASDAQ CDLX)Community Ranking: 2.1 out of 5 ( )Outperform Votes: 73 (Vote Outperform)Underperform Votes: 98 (Vote Underperform)Total Votes: 171MarketBeat's community ratings are surveys of what our community members think about Cardlytics and other stocks. Vote "Outperform" if you believe CDLX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CDLX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/19/2018 by MarketBeat.com StaffFeatured Article: Do You Need a Fiduciary?